“Bimekizumab 3-Year Maintenance of Response in Week 16 Responders With Moderate to Severe Plaque Psoriasis: Results from Five Phase 3 3b Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s306. Accessed July 22, 2025. https://skin.dermsquared.com/skin/article/view/2452.